Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome.
Tanaka
T
T
Department of Pediatrics, National Kure Hospital, Hiroshima, Japan.
D014408:Biomarkers, Tumor / Q000032:analysis*; D015139:Blotting, Southern; D002675:Child, Preschool; D005260:Female; D005784:Gene Amplification; D016259:Genes, myc; D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009447:Neuroblastoma / Q000175:diagnosis* / Q000401:mortality; D011237:Predictive Value of Tests; D011379:Prognosis; D016283:Proto-Oncogene Proteins p21(ras) / Q000032:analysis*; D012189:Retrospective Studies; D016019:Survival Analysis
D014408:Biomarkers, Tumor; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)